Department of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine / School of Public Health, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.
Division of Health Care Research, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045 Tokyo, Japan.
J Psychiatr Res. 2018 Jul;102:72-80. doi: 10.1016/j.jpsychires.2018.03.015. Epub 2018 Apr 3.
The efficacy of omega-3 fatty acids for maintaining a better mental state has not been examined among working populations. We aimed to explore the effectiveness of omega-3 fatty acids for hospital nurses. In a multi-center randomized trial, 80 junior nurses were randomly allocated to either omega-3 fatty acids (1200 mg/day of eicosapentaenoic acid and 600 mg/day of docosahexaenoic acid) or identical placebo pills for 13 weeks. The primary outcome was the total score of the Hospital Anxiety and Depression Scale (HADS), determined by a blinded rater at week 26 from the study enrolment. Secondary outcomes included the total score of the HADS at 13 and 52 weeks; incidence of a major depressive episode; severity of depression, anxiety, insomnia, burnout, and presenteeism; utility scores; and adverse events at 13, 26 and 52 weeks. The mean HADS score at baseline was 7.2. At 26 weeks, adjusted mean scores on the HADS were 6.32 (95% CIs of standard errors: 5.13, 7.52) in the intervention and 6.81 (5.57, 8.05) in the placebo groups, respectively. The coefficient of the group by time interaction was not statistically significant at 0.58 (-1.35, 2.50; P = 0.557). Although the intervention group showed significant superiority on the HADS score at 52 weeks, depression severity at 52 weeks, insomnia severity at 13 weeks, and absolute presenteeism at 26 weeks, no significant superiority or inferiority was observed on the other outcomes. The additive value of omega-3 fatty acids was not confirmed regarding mental state and self-evaluated work efficiency.
ω-3 脂肪酸在改善精神状态方面的功效在工作人群中尚未得到检验。我们旨在探讨 ω-3 脂肪酸对医院护士的有效性。在一项多中心随机试验中,80 名初级护士被随机分配至 ω-3 脂肪酸组(每天 1200mg 二十碳五烯酸和 600mg 二十二碳六烯酸)或相同的安慰剂组,疗程为 13 周。主要结局是由盲法评估者在研究入组后第 26 周评估的医院焦虑和抑郁量表(HADS)总分。次要结局包括 HADS 总分在第 13 周和第 52 周的变化;重性抑郁发作的发生率;抑郁、焦虑、失眠、倦怠和出勤情况的严重程度;效用评分;以及第 13、26 和 52 周的不良事件。基线时 HADS 平均评分为 7.2。26 周时,干预组 HADS 调整后的平均评分分别为 6.32(95%可信区间的标准误差:5.13,7.52),安慰剂组为 6.81(5.57,8.05)。组间时间交互作用的系数在统计学上无显著意义(0.58;-1.35,2.50;P=0.557)。尽管干预组在第 52 周时 HADS 评分、第 52 周时抑郁严重程度、第 13 周时失眠严重程度和第 26 周时绝对出勤情况显示出显著优势,但在其他结局方面未观察到显著的优势或劣势。ω-3 脂肪酸对精神状态和自我评估的工作效率没有明显的附加价值。